Valerio De Stefano
Valerio De Stefano
Full Professor of Hematology, Catholic University, Italy
Email verificata su unicatt.it
TitoloCitata daAnno
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial
A Palumbo, S Bringhen, T Caravita, E Merla, V Capparella, V Callea, ...
The Lancet 367 (9513), 825-831, 2006
9212006
Inherited thrombophilia: pathogenesis, clinical syndromes, and management
V De Stefano, G Finazzi, PM Mannucci
BLOOD-NEW YORK- 87, 3531-3544, 1996
6431996
The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation
V De Stefano, I Martinelli, PM Mannucci, K Paciaroni, P Chiusolo, ...
New England Journal of Medicine 341 (11), 801-806, 1999
5961999
Cardiovascular events and intensity of treatment in polycythemia vera
R Marchioli, G Finazzi, G Specchia, R Cacciola, R Cavazzina, D Cilloni, ...
New England Journal of Medicine 368 (1), 22-33, 2013
4882013
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry
G Finazzi, V Brancaccio, M Moia, N Ciavarella, MG Mazzucconi, ...
The American journal of medicine 100 (5), 530-536, 1996
4801996
Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families
I Martinelli, PM Mannucci, V De Stefano, E Taioli, V Rossi, F Crosti, ...
Blood 92 (7), 2353-2358, 1998
4751998
Clinical profile of homozygous JAK2 617V> F mutation in patients with polycythemia vera or essential thrombocythemia
AM Vannucchi, E Antonioli, P Guglielmelli, A Rambaldi, G Barosi, ...
Blood 110 (3), 840-846, 2007
4662007
Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism
J Emmerich, FR Rosendaal, M Cattaneo, M Margaglione, V De Stefano, ...
Thrombosis and haemostasis 86 (09), 809-816, 2001
4182001
Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera
R Landolfi, L Di Gennaro, T Barbui, V De Stefano, G Finazzi, RM Marfisi, ...
Blood 109 (6), 2446-2452, 2007
3492007
Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients
V De Stefano, P Chiusolo, K Paciaroni, I Casorelli, E Rossi, M Molinari, ...
Blood 91 (10), 3562-3565, 1998
3011998
Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)
T Barbui, G Finazzi, A Carobbio, J Thiele, F Passamonti, E Rumi, ...
Blood 120 (26), 5128-5133, 2012
2742012
Epidemiology of factor V Leiden: clinical implications
V de Stefano, P Chiusolo, K Paciaroni, G Leone
Seminars in thrombosis and hemostasis 24 (04), 367-379, 1998
2671998
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with …
M Cavo, L Pantani, MT Petrucci, F Patriarca, E Zamagni, D Donnarumma, ...
Blood 120 (1), 9-19, 2012
2592012
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments
V De Stefano, T Za, E Rossi, AM Vannucchi, M Ruggeri, E Elli, C Micò, ...
haematologica 93 (3), 372-380, 2008
2432008
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia
F Zaja, M Baccarani, P Mazza, M Bocchia, L Gugliotta, A Zaccaria, ...
Blood 115 (14), 2755-2762, 2010
2322010
Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium
I Martinelli, V De Stefano, E Taioli, K Paciaroni, E Rossi, MM Pier
Thrombosis and haemostasis 87 (05), 791-795, 2002
2152002
Screening for inherited thrombophilia: indications and therapeutic implications
V De Stefano, E Rossi, K Paciaroni, G Leone
haematologica 87 (10), 1095-1108, 2002
2132002
Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders
V De Stefano, A Fiorini, E Rossi, G Farina, P Chiusolo, S Sica, G Leone
Journal of Thrombosis and Haemostasis 5 (4), 708-714, 2007
1992007
Clinical manifestations and management of inherited thrombophilia: retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of …
V De Stefano, G Leone, S Mastrangelo, A Tripodi, F Rodeghiero, ...
Thrombosis and haemostasis 71 (03), 352-358, 1994
1991994
Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter …
P Bucciarelli, FR Rosendaal, A Tripodi, PM Mannucci, V De Stefano, ...
Arteriosclerosis, thrombosis, and vascular biology 19 (4), 1026-1033, 1999
1821999
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20